: Protection from viral infections depends on immunoglobulin isotype switching, which endows antibodies with effector functions. Here, we find that the protein kinase DYRK1A is essential for B cell-mediated protection from viral infection and effective vaccination through regulation of class switch recombination (CSR). Dyrk1a-deficient B cells are impaired in CSR activity in vivo and in vitro. Phosphoproteomic screens and kinase-activity assays identify MSH6, a DNA mismatch repair protein, as a direct substrate for DYRK1A, and deletion of a single phosphorylation site impaired CSR. After CSR and germinal center (GC) seeding, DYRK1A is required for attenuation of B cell proliferation. These findings demonstrate DYRK1A-mediated biological mechanisms of B cell immune responses that may be used for therapeutic manipulation in antibody-mediated autoimmunity.
B cell class switch recombination is regulated by DYRK1A through MSH6 phosphorylation / Stoler-Barak, L.; Harris, E.; Peres, A.; Hezroni, H.; Kuka, M.; Di Lucia, P.; Grenov, A.; Gurwicz, N.; Kupervaser, M.; Yip, B. H.; Iannacone, M.; Yaari, G.; Crispino, J. D.; Shulman, Z.. - In: NATURE COMMUNICATIONS. - ISSN 2041-1723. - 14:1(2023), p. 1462. [10.1038/s41467-023-37205-5]
B cell class switch recombination is regulated by DYRK1A through MSH6 phosphorylation
Kuka M.;Iannacone M.;
2023-01-01
Abstract
: Protection from viral infections depends on immunoglobulin isotype switching, which endows antibodies with effector functions. Here, we find that the protein kinase DYRK1A is essential for B cell-mediated protection from viral infection and effective vaccination through regulation of class switch recombination (CSR). Dyrk1a-deficient B cells are impaired in CSR activity in vivo and in vitro. Phosphoproteomic screens and kinase-activity assays identify MSH6, a DNA mismatch repair protein, as a direct substrate for DYRK1A, and deletion of a single phosphorylation site impaired CSR. After CSR and germinal center (GC) seeding, DYRK1A is required for attenuation of B cell proliferation. These findings demonstrate DYRK1A-mediated biological mechanisms of B cell immune responses that may be used for therapeutic manipulation in antibody-mediated autoimmunity.File | Dimensione | Formato | |
---|---|---|---|
s41467-023-37205-5.pdf
accesso aperto
Tipologia:
PDF editoriale (versione pubblicata dall'editore)
Licenza:
Creative commons
Dimensione
4.22 MB
Formato
Adobe PDF
|
4.22 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.